DrugCite
Search

PRETERAX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Preterax Adverse Events Reported to the FDA Over Time

How are Preterax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Preterax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Preterax is flagged as the suspect drug causing the adverse event.

Most Common Preterax Adverse Events Reported to the FDA

What are the most common Preterax adverse events reported to the FDA?

Loss Of Consciousness
11 (3.56%)
Hyponatraemia
9 (2.91%)
Blood Creatinine Increased
7 (2.27%)
Dehydration
7 (2.27%)
Fall
7 (2.27%)
Hyperkalaemia
6 (1.94%)
Torsade De Pointes
6 (1.94%)
Asthenia
5 (1.62%)
Cardiac Arrest
5 (1.62%)
Face Oedema
5 (1.62%)
Palatal Oedema
5 (1.62%)
Show More Show More
Renal Failure
5 (1.62%)
Renal Failure Acute
5 (1.62%)
Sinus Bradycardia
5 (1.62%)
Tachycardia
5 (1.62%)
Ventricular Hypertrophy
5 (1.62%)
Acute Generalised Exanthematous Pus...
4 (1.29%)
Bundle Branch Block Left
4 (1.29%)
Drug Interaction
4 (1.29%)
General Physical Health Deteriorati...
4 (1.29%)
Hypokalaemia
4 (1.29%)
Lip Oedema
4 (1.29%)
Malaise
4 (1.29%)
Myalgia
4 (1.29%)
Orthostatic Hypotension
4 (1.29%)
Ventricular Extrasystoles
4 (1.29%)
Agitation
3 (.97%)
Angina Pectoris
3 (.97%)
Arrhythmia
3 (.97%)
Blood Potassium Increased
3 (.97%)
Blood Pressure Increased
3 (.97%)
Chest Pain
3 (.97%)
Congestive Cardiomyopathy
3 (.97%)
Creatinine Renal Clearance Decrease...
3 (.97%)
Deep Vein Thrombosis
3 (.97%)
Electrocardiogram Qt Prolonged
3 (.97%)
Hypotension
3 (.97%)
Nausea
3 (.97%)
Pyrexia
3 (.97%)
Syncope
3 (.97%)
Anorexia
2 (.65%)
Arthralgia
2 (.65%)
Benign Prostatic Hyperplasia
2 (.65%)
Bladder Distension
2 (.65%)
Blood Creatine Phosphokinase Increa...
2 (.65%)
Brain Death
2 (.65%)
C-reactive Protein Increased
2 (.65%)
Cerebral Haemorrhage
2 (.65%)
Confusional State
2 (.65%)
Drug Administration Error
2 (.65%)
Eructation
2 (.65%)
Headache
2 (.65%)
Hearing Impaired
2 (.65%)
Hepatic Failure
2 (.65%)
Hypernatraemia
2 (.65%)
Hypertension
2 (.65%)
Hypotonia
2 (.65%)
Iatrogenic Injury
2 (.65%)
Meningitis
2 (.65%)
Muscle Spasms
2 (.65%)
Muscular Weakness
2 (.65%)
Photophobia
2 (.65%)
Polyuria
2 (.65%)
Postrenal Failure
2 (.65%)
Pruritus
2 (.65%)
Respiratory Failure
2 (.65%)
Supraventricular Extrasystoles
2 (.65%)
Troponin Increased
2 (.65%)
Visual Impairment
2 (.65%)
Abnormal Behaviour
1 (.32%)
Agranulocytosis
1 (.32%)
Anxiety
1 (.32%)
Atrial Fibrillation
1 (.32%)
Atrial Flutter
1 (.32%)
Balance Disorder
1 (.32%)
Blood Cortisol Increased
1 (.32%)
Blood Urea Increased
1 (.32%)
Brain Herniation
1 (.32%)
Brain Natriuretic Peptide Increased
1 (.32%)
Brain Scan Abnormal
1 (.32%)
Cardiac Flutter
1 (.32%)
Cardiac Murmur
1 (.32%)
Cell Death
1 (.32%)
Cerebral Atrophy
1 (.32%)
Chest Discomfort
1 (.32%)
Chills
1 (.32%)
Cholestasis
1 (.32%)
Condition Aggravated
1 (.32%)
Convulsion
1 (.32%)
Cyclitis
1 (.32%)
Cytolytic Hepatitis
1 (.32%)
Diarrhoea Haemorrhagic
1 (.32%)
Dilatation Atrial
1 (.32%)
Dyspnoea
1 (.32%)
Electrocardiogram P Wave Abnormal
1 (.32%)
Eyelid Oedema
1 (.32%)
Feeling Hot
1 (.32%)
Haemoglobin Decreased
1 (.32%)
Haemolytic Anaemia
1 (.32%)
Heart Rate Irregular
1 (.32%)
Hyperglobulinaemia
1 (.32%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Preterax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Preterax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Preterax

What are the most common Preterax adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Preterax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Preterax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Preterax According to Those Reporting Adverse Events

Why are people taking Preterax, according to those reporting adverse events to the FDA?

Hypertension
74
Drug Use For Unknown Indication
20
Product Used For Unknown Indication
12
Essential Hypertension
8
Prophylaxis
2
Tachycardia
2
Show More Show More
Cerebrovascular Accident
2
Ill-defined Disorder
1

Preterax Case Reports

What Preterax safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Preterax. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Preterax.